Roberta Nicoletti

521 total citations
14 papers, 324 citations indexed

About

Roberta Nicoletti is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Roberta Nicoletti has authored 14 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Roberta Nicoletti's work include HER2/EGFR in Cancer Research (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cancer, Lipids, and Metabolism (2 papers). Roberta Nicoletti is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Cancer, Lipids, and Metabolism (2 papers). Roberta Nicoletti collaborates with scholars based in Italy, United States and China. Roberta Nicoletti's co-authors include Delia Mezzanzanica, Silvana Canevari, Marina Bagnoli, Egidio Iorio, Franca Podo, Loris De Cecco, Carlton L. Schwab, Thomas Rutherford, Peter E. Schwartz and Emiliano Cocco and has published in prestigious journals such as Cancer Research, British Journal of Cancer and Oncotarget.

In The Last Decade

Roberta Nicoletti

14 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberta Nicoletti Italy 9 163 127 84 53 52 14 324
Renato José Affonso Brazil 7 81 0.5× 83 0.7× 106 1.3× 81 1.5× 32 0.6× 9 288
Liudmila Velikokhatnaya United States 6 113 0.7× 76 0.6× 95 1.1× 83 1.6× 40 0.8× 7 359
Jitka Hausnerová Czechia 10 142 0.9× 93 0.7× 70 0.8× 63 1.2× 34 0.7× 37 297
Elena Martínez-García Spain 9 178 1.1× 137 1.1× 48 0.6× 98 1.8× 36 0.7× 11 316
Giuseppina Improta Italy 13 263 1.6× 80 0.6× 206 2.5× 20 0.4× 122 2.3× 31 468
C. Mendiola Spain 11 86 0.5× 67 0.5× 185 2.2× 69 1.3× 71 1.4× 28 388
Arpita Desai United States 10 229 1.4× 116 0.9× 165 2.0× 16 0.3× 185 3.6× 38 451
Xiaohong Ma China 10 161 1.0× 105 0.8× 84 1.0× 29 0.5× 45 0.9× 22 305
Chunfang Ha China 9 160 1.0× 117 0.9× 76 0.9× 64 1.2× 23 0.4× 25 308
Jane Borley United Kingdom 9 294 1.8× 162 1.3× 106 1.3× 71 1.3× 38 0.7× 15 497

Countries citing papers authored by Roberta Nicoletti

Since Specialization
Citations

This map shows the geographic impact of Roberta Nicoletti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Nicoletti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Nicoletti more than expected).

Fields of papers citing papers by Roberta Nicoletti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Nicoletti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Nicoletti. The network helps show where Roberta Nicoletti may publish in the future.

Co-authorship network of co-authors of Roberta Nicoletti

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Nicoletti. A scholar is included among the top collaborators of Roberta Nicoletti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Nicoletti. Roberta Nicoletti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Verde, Marco La, et al.. (2023). Pelvic Organ Prolapse Syndrome and Lower Urinary Tract Symptom Update: What’s New?. Healthcare. 11(10). 1513–1513. 5 indexed citations
2.
Bagnoli, Marina, et al.. (2022). Impairment of RAD17 Functions by miR-506-3p as a Novel Synthetic Lethal Approach Targeting DNA Repair Pathways in Ovarian Cancer. Frontiers in Oncology. 12. 923508–923508. 5 indexed citations
3.
Ronsini, Carlo, L Mosca, Irene Iavarone, et al.. (2022). Oncological outcomes in fertility-sparing treatment in stage IA-G2 endometrial cancer. Frontiers in Oncology. 12. 965029–965029. 22 indexed citations
4.
Bagnoli, Marina, Roberta Nicoletti, Balaji Krishnamachary, et al.. (2016). Choline Metabolism Alteration: A Focus on Ovarian Cancer. Frontiers in Oncology. 6. 153–153. 46 indexed citations
5.
Nicoletti, Roberta, Paola Perego, Egidio Iorio, et al.. (2015). Global metabolic profile identifies choline kinase alpha as a key regulator of glutathione-dependent antioxidant cell defense in ovarian carcinoma. Oncotarget. 6(13). 11216–11230. 20 indexed citations
6.
Schwab, Carlton L., Dana M. Roque, Diana P. English, et al.. (2015). Afatinib, an irreversible ErbB family blocker, demonstrates remarkable activity against HER2 amplified uterine serous endometrial cancer in vitro and in vivo. Gynecologic Oncology. 136(2). 397–398. 1 indexed citations
7.
Schwab, Carlton L., Diana P. English, Dana M. Roque, et al.. (2014). Neratinib shows efficacy in the treatment of HER2/neu amplified uterine serous carcinoma in vitro and in vivo. Gynecologic Oncology. 135(1). 142–148. 27 indexed citations
8.
Schwab, Carlton L., Stefania Bellone, Diana P. English, et al.. (2014). Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo. British Journal of Cancer. 111(9). 1750–1756. 21 indexed citations
9.
Nicoletti, Roberta, Salvatore Lopez, Stefania Bellone, et al.. (2014). T-DM1, a novel antibody-drug conjugate, is highly effective against uterine and ovarian carcinosarcomas overexpressing HER2. Clinical & Experimental Metastasis. 32(1). 29–38. 50 indexed citations
10.
Lopez, Salvatore, Emiliano Cocco, Stefania Bellone, et al.. (2014). Abstract 4498: Afatinib, an irreversible ErbB family inhibitor, demonstrates activity against HER2 mutated cervical cancer in vitro. Cancer Research. 74(19_Supplement). 4498–4498. 1 indexed citations
11.
Nicoletti, Roberta, Loris De Cecco, Maria Elena Pisanu, et al.. (2013). Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancer. British Journal of Cancer. 110(2). 330–340. 46 indexed citations
12.
Nicoletti, Roberta, et al.. (2013). The Health of Dialysis Patients is in Our Hands. 25(3). 240–243. 3 indexed citations
13.
Bagnoli, Marina, Loris De Cecco, Roberta Nicoletti, et al.. (2011). Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients. Oncotarget. 2(12). 1265–1278. 52 indexed citations
14.
Cammarata, Giuseppe, Roberta Nicoletti, Maria Luisa Coniglio, et al.. (2010). 14q32/miRNA Clusters loss of heterozygosity in acute lymphoblastic leukemia is associated with up‐regulation of BCL11a. American Journal of Hematology. 85(8). 575–578. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026